These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 5110789
21. [Treatment of parkinsonism with benzhexole (Artane and Artane-sequel)]. Vestberg F. Ugeskr Laeger; 1967 Nov 09; 129(45):1511-2. PubMed ID: 5594302 [No Abstract] [Full Text] [Related]
22. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor]. Guillard A. Brux Med; 1972 Oct 09; 52(10):673-80. PubMed ID: 4656191 [No Abstract] [Full Text] [Related]
27. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB, Shealy CN, Mercier DA. Wis Med J; 1969 Nov 09; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
28. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa]. Bergamini L, Bonzanino A, Bignolio F, Fabiani A, Fariello R, Mombelli AM, Mutani R, Pisani W, Postir A, Riccio A, Sabbatini F, Sandigliano G, Schiffer D. Riv Patol Nerv Ment; 1970 Feb 09; 91(1):10-6. PubMed ID: 5524931 [No Abstract] [Full Text] [Related]
29. [Personal experience in the treatment of Parkinson's disease with L-Dopa]. Figuerido JA, De la Herrán J. Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794 [No Abstract] [Full Text] [Related]
30. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE. Trans Am Neurol Assoc; 1971 Dec 31; 96():55-8. PubMed ID: 5159129 [No Abstract] [Full Text] [Related]
31. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism. Mones RJ, Elizan TS. J Mt Sinai Hosp N Y; 1969 Dec 31; 36(6):503-15. PubMed ID: 5261089 [No Abstract] [Full Text] [Related]
32. Levodopa and dopamine in cerebrospinal fluid. Papavasiliou PS, Cotzias GC, Lawrence WH. Neurology; 1973 Jul 31; 23(7):756-9. PubMed ID: 4736493 [No Abstract] [Full Text] [Related]
33. L-dopa and parkinsonism. Okihiro MM. Hawaii Med J; 1971 Jul 31; 30(5):390-2. PubMed ID: 5160226 [No Abstract] [Full Text] [Related]
35. [Treatment of parkinsonism with L-dopa]. Hernández Peniche J, Martínez Villar C, De León Charles C. Rev Invest Clin; 1971 Jul 31; 23(2):125-32. PubMed ID: 5114336 [No Abstract] [Full Text] [Related]
36. [Analysis of the effects of L-dopa during a 3-month course of treatment]. Pinto F, Venturini E. Riv Neurobiol; 1970 Jul 31; 16(4):415-28. PubMed ID: 4949926 [No Abstract] [Full Text] [Related]
37. L-DOPA treatment for Parkinsonism: analysis of functional improvement. Jonas S. Arch Phys Med Rehabil; 1971 Dec 31; 52(12):560-2. PubMed ID: 5136441 [No Abstract] [Full Text] [Related]
38. [Parkinsonism and L-dopa: our 1st results]. Warot P, Petit H, Chevalier-Lefebvre J, Herbaut G. Lille Med; 1971 May 31; 16(5):765-7. PubMed ID: 5115349 [No Abstract] [Full Text] [Related]
39. The treatment of parkinsonism with L-Dopa and amantadine. Green J. J Fla Med Assoc; 1970 Jun 31; 57(6):28-33. PubMed ID: 5445813 [No Abstract] [Full Text] [Related]
40. [Clinical electroencephalographic studies during the treatment of parkinsonism with an L-DOPA preparation]. Krasnov EA, Romenskaia LKh. Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Jun 31; 73(4):520-3. PubMed ID: 4705406 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]